Dr. Beverly Gray, an associate professor of obstetrics and gynecology at Duke University says, “Women’s pain and women’s experiences have been downplayed throughout medicine.”? This is why we at CrossBay developed CrossGlide. Women shouldn't be forced to feel what some describe as a "hot knife slowly stabbing them." Freedom from pain is possible. Its time we update clinical protocols and technology. https://lnkd.in/g6u48T34 The New York Times Teddy Rosenbluth CrossBay Medical Inc.
CrossBay Medical Inc.
医疗设备
San Diego，California 468 位关注者
Reimagining Women’s Health through Medical Device Technology
关于我们
CrossBay is a Women’s Health Company that believes 51% of the world’s population is grossly underserved due to the state of trans-cervical uterine medical devices. We are replacing age-old technologies with our anatomically adaptive CrossGlideTM products to empower physicians to deliver more compassionate in-office care. We plan to develop and commercialize additional medical devices using CrossGlide? across a wide array of gynecological applications as we work to improve the quality of life and healthcare for women.
- 网站
-
https://www.crossbaymedicalinc.com
CrossBay Medical Inc.的外部链接
- 所属行业
- 医疗设备
- 规模
- 2-10 人
- 总部
- San Diego，California
- 类型
- 私人持股
- 创立
- 2009
- 领域
- Medical Device Industry、Women's Health, Children's Health and Preventive Home healthcare和Development, manufacturing, distribution and promotion of affordable solutions
地点
-
主要
获取路线
13240 Evening Creek Dr S
suite 304
US，California，San Diego，92128
CrossBay Medical Inc.员工
-
Piush Vidyarthi
CEO at CrossBay Medical, Inc.
-
Steven Bacich
President & COO NEXT Life Sciences, Inc. - Co-founder MED1 Ventures, Inc. - Board Member CIO CrossBay Medical - Acting CEO Aardvark Medical
-
Xin Zhao
Sales Director
-
Cristiano Fontana
MedTech Strategic Advisor, Board Member and Investor
动态
-
Great article on what CrossGlide is and the applications it has and can be used for in the future. The improvement here is that by design the catheter is flexible and frictionless and therefore, no rigid tube is used to push across the cervix. Therefore, it shouldn't cause trauma. We don't need the use of a tenaculum (forceps as you call it) to apply counter-traction to the cervix. This is proven in our other products for endometrial biopsy, embryo transfer, and cervical dilation.
Senior Vice President | MedTech and Digital Health Strategist | MSK and Women's Health Thought Leader
Its #WomensHealthWednesday again! Bayer, a leader in the intrauterine #contraception space, announced an exciting collaboration last week with CrossBay Medical Inc. that will aim to improve the intrauterine system (IUS) placement experience for patients (https://lnkd.in/eQhnZhxF). The agreement allows for the development of a single-handed inserter to be combined with Bayer’s IUS products using CrossBay’s CrossGlide uterine access platform, with eventual option to license. CrossGlide uses a flexible catheter that follows the natural curves of the cervical canal, replacing the need for forceps during the IUS placement procedure. CrossGlide has numerous #gynecological applications, previously having been cleared for use in endometrial biopsy procedures, licensed to Vitrolife for use in an embryo transfer catheter, and licensed to Hologic, Inc. for use in a cervical dilator product. Through this collaboration, the companies hope to improve the IUS placement experience by reducing the discomfort and #pain many women feel during the procedure. It remains to be seen how this innovation could impact overall IUS procedure costs – while a more advanced insertion device could raise the cost of an IUS, the potential benefits may include elimination of costs tied to purchase/reprocessing of the instruments that the novel inserter will replace and reduced total procedure time.? This collaboration validates the pain that many women experience during IUS/IUD placement, a topic which has long been pushed aside. Bayer must see this as an area of particularly high unmet need, given that the company had previously announced plans to deprioritize R&D investment in women’s health earlier in 2023. When selecting a form of contraception, fear of pain during the IUS/IUD procedure drives many women to choose other options. It will be interesting to see if by improving the patient experience, the total IUS/IUD market size will eventually expand. Interested in learning more about Health Advances Women's Health capabilities? Reach out to our team! Susan Posner Kristen Garner Amanti Jeffrey Abraham Dr. Marcus A. Koch, CFA Masha Dumanis Thanks to Jessica Dubuque for contributions to today's content.
Bayer taps CrossBay’s uterus access device to make IUD placements less painful
fiercebiotech.com
-
It’s time to finally change the paradigm!
Bayer taps CrossBay’s uterus access device to make IUD placements less painful
fiercebiotech.com
-
I am happy to announce this win for women’s health!! It’s been a personal goal of mine to help change the standard of care for procedures performed in the office for typical gynecological procedures. This partnership will go a long way towards achieving that goal. I look forward to working with Bayer.
+++ #NEWS +++ Bayer teams up with CrossBay Medical Inc. to further drive innovation for women worldwide by developing a novel intrauterine system inserter. Learn more: https://spr.ly/6042RD1eG #womenshealth #TeamBayer #healthforallhungerfornone
-
-
I am happy to announce this win for women’s health!! It’s been a personal goal of mine to help change the standard of care for procedures performed in the office for typical gynecological procedures. This partnership will go a long way towards achieving that goal. I look forward to working with Bayer.
+++ #NEWS +++ Bayer teams up with CrossBay Medical Inc. to further drive innovation for women worldwide by developing a novel intrauterine system inserter. Learn more: https://spr.ly/6042RD1eG #womenshealth #TeamBayer #healthforallhungerfornone
-
-
Head of Leaps by Bayer and Head of Pharmaceuticals Business Development and Licensing. Executive Vice President, MD, MBA
As a leader in women’s healthcare, we are proud to collaborate with CrossBay Medical Inc.. We are continually listening to and addressing women’s concerns and their lived experiences, especially when evaluating #innovation. ? #TeamBayer
+++ #NEWS +++ Bayer teams up with CrossBay Medical Inc. to further drive innovation for women worldwide by developing a novel intrauterine system inserter. Learn more: https://spr.ly/6042RD1eG #womenshealth #TeamBayer #healthforallhungerfornone
-
-
Head of Leaps by Bayer and Head of Pharmaceuticals Business Development and Licensing. Executive Vice President, MD, MBA
As a leader in women’s healthcare, we are proud to collaborate with CrossBay Medical Inc.. We are continually listening to and addressing women’s concerns and their lived experiences, especially when evaluating #innovation. ? #TeamBayer
+++ #NEWS +++ Bayer teams up with CrossBay Medical Inc. to further drive innovation for women worldwide by developing a novel intrauterine system inserter. Learn more: https://spr.ly/6042RD1eG #womenshealth #TeamBayer #healthforallhungerfornone
-
-
Cheers to Bayer for seeing the value in improving how women experience IUD placement! Adding CrossGlide to the inserter will reduce discomfort, which is often the sole reason to avoid this procedure for many women. The mission of CrossBay has always been to improve how women experience the most common procedures. CrossGlide is a platform technology that can change the way uterine biopsies, hysteroscopy, IVF treatment, or any procedure requiring access to the uterus through the cervical canal. Congratulations to the entire CrossBay team! This relationship with Bayer is a great bellwether to integrate CrossGlide further and bring it forward into all uterine health procedures.#bayerpharmaceuticals #crossbaymedical https://lnkd.in/g_iRGNq7
Bayer and CrossBay Medical to develop novel Intrauterine System Inserter
businesswire.com